Potential biomarker of metformin action.

Abstract excerpt

Metformin is a first-line, anti-diabetic agent prescribed to over 150 million people worldwide. The main effect of metformin is to suppress glucose production in the liver; however, there is no reliable biomarker to assess the effectiveness of metformin administration. Our previous studies have shown that phosphorylation of CBP at S436 is important for the regulation of hepatic glucose production by metformin. In...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CREB-Binding Protein
• Share to Fasting
• Share to Gluconeogenesis